Low-Dose Decitabine in Treating Patients With Symptomatic Myelofibrosis
Status:
Terminated
Trial end date:
2012-04-01
Target enrollment:
Participant gender:
Summary
RATIONALE: Drugs used in chemotherapy, such as decitabine, work in different ways to stop the
growth of cancer cells, either by killing the cells or by stopping them from dividing.
PURPOSE: This phase II trial is studying the side effects and how well low-dose decitabine
works in treating patients with symptomatic myelofibrosis.